Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV. (Q48627331)

13 February 2018

title

Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV. (English)

1 reference

13 February 2018

1 reference

Masahiro Toda

1

1 reference

13 February 2018

Yukihiko Iizuka

2

1 reference

13 February 2018

Takeshi Kawase

3

1 reference

13 February 2018

Keiichi Uyemura

4

1 reference

13 February 2018

Yutaka Kawakami

5

1 reference

13 February 2018

publication date

1 April 2002

1 reference

13 February 2018

published in

Cancer Gene Therapy

1 reference

13 February 2018

volume

9

1 reference

13 February 2018

issue

4

1 reference

13 February 2018

page(s)

356-364

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700446

exact match

0 references

cites work

T-cell autoimmunity in the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Direct demonstration of the infiltration of murine central nervous system by Pgp-1/CD44high CD45RB(low) CD4+ T cells that induce experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Cost and survival analysis of metastatic cerebral tumors treated by resection and radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Surgery versus radiosurgery in the treatment of brain metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Surgical treatment of multiple brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Preparation of membrane fraction from herpes simplex virus-infected cells which induce cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Brain-derived gangliosides induce cell cycle arrest in a murine T cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Conditionally replicating herpes vectors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

Intracerebral metastases in solid-tumor patients: Natural history and results of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

1 reference

7 January 2021

Systemic immunity against a murine colon tumor (CT-26) produced by immunization with syngeneic cells expressing a transfected viral gene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

7 January 2021

In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

7 January 2021

Immune response against tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700446

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700446

1 reference

13 February 2018

1 reference

13 February 2018